Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Differential effect of surgical technique on intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial cancer: a systematic review and Meta-analysis

I. Tsuboi, A. Matsukawa, M. Kardoust Parizi, J. Klemm, RJ. Schulz, A. Cadenar, S. Mancon, S. Chiujdea, T. Fazekas, M. Miszczyk, E. Laukhtina, T. Kawada, S. Katayama, T. Iwata, K. Bekku, K. Wada, P. Gontero, M. Rouprêt, J. Teoh, N. Singla, M....

. 2024 ; 42 (1) : 488. [pub] 20240820

Jazyk angličtina Země Německo

Typ dokumentu systematický přehled, časopisecké články, metaanalýza

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019306

CONTEXT: Radical nephroureterectomy (RNU) with bladder cuff resection is the standard treatment in patients with high-risk upper tract urothelial cancer (UTUC). However, it is unclear which specific surgical technique may lead to improve oncological outcomes in term of intravesical recurrence (IVR) in patients with UTUC. OBJECTIVE: To evaluate the efficacy of surgical techniques and approaches of RNU in reducing IVR in UTUC patients. EVIDENCE ACQUISITION: Three databases were queried in January 2024 for studies analyzing UTUC patients who underwent RNU. The primary outcome of interest was the rate of IVR among various types of surgical techniques and approaches of RNU. EVIDENCE SYNTHESIS: Thirty-one studies, comprising 1 randomized controlled trial and 1 prospective study, were included for a systematic review and meta-analysis. The rate of IVR was significantly lower in RNU patients who had an early ligation (EL) of the ureter compared to those who did not (HR: 0.64, 95% CI: 0.44-0.94, p = 0.02). Laparoscopic RNU significantly increased the IVR compared to open RNU (HR: 1.28, 95% CI: 1.06-1.54, p < 0.001). Intravesical bladder cuff removal significantly reduced the IVR compared to both extravesical and transurethral bladder cuff removal (HR: 0.65, 95% CI: 0.51-0.83, p = 0.02 and HR: 1.64, 95% CI: 1.15-2.34, p = 0.006, respectively). CONCLUSIONS: EL of the affected upper tract system, ureteral management, open RNU, and intravesical bladder cuff removal seem to yield the lowest IVR rate in patients with UTUC. Well-designed prospective studies are needed to conclusively elucidate the optimal surgical technique in the setting of single post-operative intravesical chemotherapy.

Collegium Medicum Faculty of Medicine WSB University Dąbrowa Górnicza Poland

Department of Biomedical Sciences Humanitas University Pieve Emanuele Italy

Department of Surgery S H Ho Urology Centre The Chinese University of Hong Kong Hong Kong SAR China

Department of Urology 2nd Faculty of Medicine Charles University Prague Czechia Czechia

Department of Urology Comprehensive Cancer Center Medical University Vienna Vienna General Hospital Währinger Gürtel 18 20 Vienna A 1090 Austria

Department of Urology Dentistry and Pharmaceutical Sciences Okayama University Graduate School of Medicine Okayama Japan

Department of Urology James Buchanan Brady Urological Institute Johns Hopkins University School of Medicine 600 North Wolfe Street Park 213 Baltimore MD 21287 USA

Department of Urology Jikei University School of Medicine Tokyo Japan

Department of Urology Semmelweis University Budapest Hungary

Department of Urology Shariati Hospital Tehran University of Medical Sciences Tehran Iran

Department of Urology Shimane University Faculty of Medicine Shimane Japan

Department of Urology Spitalul Clinic Judetean Murures University of Medicine Science and Technology of Targu Mures Pharmacy Mures Romania

Department of Urology University Medical Center Hamburg Eppendorf Hamburg Germany

Department of Urology University of Texas Southwestern Medical Center Dallas TX USA

Department of Urology Weill Cornell Medical College New York NY USA

Division of Urology Department of Special Surgery The University of Jordan Amman Jordan

Division of Urology Department of Surgical Sciences Molinette Hospital University of Turin Turin Italy

Institute for Urology and Reproductive Health Sechenov University Moscow Russia

Karl Landsteiner Institute of Urology and Andrology Vienna Austria

Research Center for Evidence Medicine Urology Department Tabriz University of Medical Sciences Tabriz Iran

Sorbonne University AP HP Pitie Salpetriere Hospital GRC 5 Predictive Onco Uro Urology PARIS F 75013 France

Unit of Oncologic Minimally Invasive Urology and Andrology Department of Experimental and Clinical Medicine Careggi Hospital University of Florence Florence Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019306
003      
CZ-PrNML
005      
20241024111510.0
007      
ta
008      
241015s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00345-024-05185-w $2 doi
035    __
$a (PubMed)39162743
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Tsuboi, Ichiro $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Department of Urology, Shimane University Faculty of Medicine, Shimane, Japan $u Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan $1 https://orcid.org/0000000231358262
245    10
$a Differential effect of surgical technique on intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial cancer: a systematic review and Meta-analysis / $c I. Tsuboi, A. Matsukawa, M. Kardoust Parizi, J. Klemm, RJ. Schulz, A. Cadenar, S. Mancon, S. Chiujdea, T. Fazekas, M. Miszczyk, E. Laukhtina, T. Kawada, S. Katayama, T. Iwata, K. Bekku, K. Wada, P. Gontero, M. Rouprêt, J. Teoh, N. Singla, M. Araki, SF. Shariat
520    9_
$a CONTEXT: Radical nephroureterectomy (RNU) with bladder cuff resection is the standard treatment in patients with high-risk upper tract urothelial cancer (UTUC). However, it is unclear which specific surgical technique may lead to improve oncological outcomes in term of intravesical recurrence (IVR) in patients with UTUC. OBJECTIVE: To evaluate the efficacy of surgical techniques and approaches of RNU in reducing IVR in UTUC patients. EVIDENCE ACQUISITION: Three databases were queried in January 2024 for studies analyzing UTUC patients who underwent RNU. The primary outcome of interest was the rate of IVR among various types of surgical techniques and approaches of RNU. EVIDENCE SYNTHESIS: Thirty-one studies, comprising 1 randomized controlled trial and 1 prospective study, were included for a systematic review and meta-analysis. The rate of IVR was significantly lower in RNU patients who had an early ligation (EL) of the ureter compared to those who did not (HR: 0.64, 95% CI: 0.44-0.94, p = 0.02). Laparoscopic RNU significantly increased the IVR compared to open RNU (HR: 1.28, 95% CI: 1.06-1.54, p < 0.001). Intravesical bladder cuff removal significantly reduced the IVR compared to both extravesical and transurethral bladder cuff removal (HR: 0.65, 95% CI: 0.51-0.83, p = 0.02 and HR: 1.64, 95% CI: 1.15-2.34, p = 0.006, respectively). CONCLUSIONS: EL of the affected upper tract system, ureteral management, open RNU, and intravesical bladder cuff removal seem to yield the lowest IVR rate in patients with UTUC. Well-designed prospective studies are needed to conclusively elucidate the optimal surgical technique in the setting of single post-operative intravesical chemotherapy.
650    _2
$a lidé $7 D006801
650    12
$a nefroureterektomie $x metody $7 D000074682
650    12
$a nádory močovodu $x chirurgie $7 D014516
650    12
$a lokální recidiva nádoru $x epidemiologie $7 D009364
650    12
$a karcinom z přechodných buněk $x chirurgie $x patologie $7 D002295
650    12
$a nádory ledvin $x chirurgie $x patologie $7 D007680
650    12
$a nádory močového měchýře $x chirurgie $x patologie $7 D001749
650    _2
$a ureter $x chirurgie $7 D014513
655    _2
$a systematický přehled $7 D000078182
655    _2
$a časopisecké články $7 D016428
655    _2
$a metaanalýza $7 D017418
700    1_
$a Matsukawa, Akihiro $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Department of Urology, Jikei University School of Medicine, Tokyo, Japan
700    1_
$a Kardoust Parizi, Mehdi $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Department of Urology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
700    1_
$a Klemm, Jakob $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Schulz, Robert J $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Cadenar, Anna $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Unit of Oncologic Minimally Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy
700    1_
$a Mancon, Stefano $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy
700    1_
$a Chiujdea, Sever $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Department of Urology, Spitalul Clinic Judetean Murures, University of Medicine, Science, and Technology of Targu Mures, Pharmacy, Mures, Romania
700    1_
$a Fazekas, Tamás $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Department of Urology, Semmelweis University, Budapest, Hungary
700    1_
$a Miszczyk, Marcin $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Collegium Medicum - Faculty of Medicine, WSB University, Dąbrowa Górnicza, Poland
700    1_
$a Laukhtina, Ekaterina $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia
700    1_
$a Kawada, Tatsushi $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan
700    1_
$a Katayama, Satoshi $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan
700    1_
$a Iwata, Takehiro $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan
700    1_
$a Bekku, Kensuke $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan
700    1_
$a Wada, Koichiro $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria $u Department of Urology, Shimane University Faculty of Medicine, Shimane, Japan
700    1_
$a Gontero, Paolo $u Division of Urology, Department of Surgical Sciences, Molinette Hospital, University of Turin, Turin, Italy
700    1_
$a Rouprêt, Morgan $u Sorbonne University, AP-HP, Pitie-Salpetriere Hospital, GRC 5 Predictive Onco-Uro, Urology, PARIS, F- 75013, France
700    1_
$a Teoh, Jeremy $u Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong SAR, China
700    1_
$a Singla, Nirmish $u Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Park 213, Baltimore, MD, 21287, USA
700    1_
$a Araki, Motoo $u Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria. shahrokh.shariat@meduniwien.ac.at $u Department of Urology, Semmelweis University, Budapest, Hungary. shahrokh.shariat@meduniwien.ac.at $u Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia. shahrokh.shariat@meduniwien.ac.at $u Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. shahrokh.shariat@meduniwien.ac.at $u Department of Urology, Weill Cornell Medical College, New York, NY, USA. shahrokh.shariat@meduniwien.ac.at $u Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czechia, Czechia. shahrokh.shariat@meduniwien.ac.at $u Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan. shahrokh.shariat@meduniwien.ac.at $u Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria. shahrokh.shariat@meduniwien.ac.at $u Research Center for Evidence Medicine, Urology Department Tabriz University of Medical Sciences, Tabriz, Iran. shahrokh.shariat@meduniwien.ac.at
773    0_
$w MED00004739 $t World journal of urology $x 1433-8726 $g Roč. 42, č. 1 (2024), s. 488
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39162743 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111504 $b ABA008
999    __
$a ok $b bmc $g 2201877 $s 1231279
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 42 $c 1 $d 488 $e 20240820 $i 1433-8726 $m World journal of urology $n World J Urol $x MED00004739
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...